CVS testing breakout resistance

CVS Health Corp (CVS) presently testing breakout resistance, able to contain weekly buying pressures. From here (CVS) can fall back to recent lows, eliciting losses of 15% over the following 1-2 months. A settlement below a near-term channel bottom would accelerate this potential selloff. Inversely, if a settlement above breakout resistance occurs, this would place (CVS) in a a buy signal where gains of 15% would be expected within 2-3 months, and 20% over the following 3-5 months.
analysisBeyond Technical AnalysisChart PatternsCVSTrend Analysis

Anthony Speciale, founder of Speciale Analysis offers an affordable approach for all traders to grow into their highest potential.
他のメディア:

免責事項